JP2024529068A5 - - Google Patents
Info
- Publication number
- JP2024529068A5 JP2024529068A5 JP2024507166A JP2024507166A JP2024529068A5 JP 2024529068 A5 JP2024529068 A5 JP 2024529068A5 JP 2024507166 A JP2024507166 A JP 2024507166A JP 2024507166 A JP2024507166 A JP 2024507166A JP 2024529068 A5 JP2024529068 A5 JP 2024529068A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- cancer
- heterocyclyl
- general formula
- compound represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110913249 | 2021-08-10 | ||
| CN202110913249.1 | 2021-08-10 | ||
| CN202111142090.4 | 2021-09-28 | ||
| CN202111142090 | 2021-09-28 | ||
| CN202111500231 | 2021-12-09 | ||
| CN202111500231.5 | 2021-12-09 | ||
| PCT/CN2022/111395 WO2023016484A1 (zh) | 2021-08-10 | 2022-08-10 | 磺酰胺衍生物、其制备方法及其在医药上的应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529068A JP2024529068A (ja) | 2024-08-01 |
| JP2024529068A5 true JP2024529068A5 (https=) | 2025-08-19 |
Family
ID=85200573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024507166A Pending JP2024529068A (ja) | 2021-08-10 | 2022-08-10 | スルファミド誘導体、その調製方法及びその医薬的使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250145637A1 (https=) |
| EP (1) | EP4385989A4 (https=) |
| JP (1) | JP2024529068A (https=) |
| KR (1) | KR20240046530A (https=) |
| CN (1) | CN117597341A (https=) |
| AU (1) | AU2022325367A1 (https=) |
| CA (1) | CA3228411A1 (https=) |
| MX (1) | MX2024001777A (https=) |
| TW (1) | TW202321263A (https=) |
| WO (1) | WO2023016484A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118556053A (zh) | 2021-11-16 | 2024-08-27 | 英矽智能科技知识产权有限公司 | 赖氨酸乙酰基转移酶6a(kat6a)抑制剂及其用途 |
| WO2023114710A1 (en) * | 2021-12-13 | 2023-06-22 | Aurigene Oncology Limited | Fused benzoisoxazolyl compounds as kat6a inhibitors |
| CN116621859A (zh) * | 2022-02-18 | 2023-08-22 | 山东轩竹医药科技有限公司 | 三并环类kat6抑制剂 |
| KR20250006833A (ko) | 2022-03-28 | 2025-01-13 | 아이소스테릭스, 인코포레이티드 | 라이신 아세틸 전이효소의 myst 계열의 억제제 |
| KR20250143814A (ko) * | 2023-02-10 | 2025-10-02 | 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 | 설폰아미드 유도체 결정 형태 및 이의 제조 방법 |
| WO2024189598A2 (en) | 2023-03-16 | 2024-09-19 | Olema Pharmaceuticals, Inc. | Acylsulfonamide kat6a inhibitors |
| CN120981721A (zh) * | 2023-03-30 | 2025-11-18 | 辉瑞大药厂 | Kat6a作为用kat6a抑制剂治疗的预测性生物标志物和相关治疗方法 |
| AU2024290895A1 (en) | 2023-07-04 | 2026-01-29 | Shanghai Qilu Pharmaceutical Research And Development Centre Ltd. | Kat6 inhibitor |
| WO2025098417A1 (zh) * | 2023-11-08 | 2025-05-15 | 再和医药科技（苏州）有限公司 | 磺酰胺类化合物及其应用 |
| WO2025101942A1 (en) * | 2023-11-10 | 2025-05-15 | Prelude Therapeutics Incorporated | Kat6 targeting compounds |
| AR134697A1 (es) * | 2023-12-18 | 2026-03-04 | Ideaya Biosciences Inc | Compuestos químicos y sus usos |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5750542A (en) * | 1993-09-28 | 1998-05-12 | Pfizer | Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors |
| HU225047B1 (en) * | 1991-03-28 | 2006-05-29 | Eisai Co Ltd | Heterocyclic-piperidin-derivatives, pharmaceutical compositions containing them and process for their production |
| WO2002074746A1 (en) * | 2001-03-16 | 2002-09-26 | Yamanouchi Pharmaceutical Co., Ltd. | Benzazepine derivatives |
| KR100965021B1 (ko) * | 2002-02-22 | 2010-06-21 | 바이엘 파마슈티칼스 코포레이션 | 과다증식성 질환 치료에 유용한 벤조푸란 및 벤조티오펜유도체 |
| AU2006281803B9 (en) * | 2005-08-18 | 2013-05-30 | Genmab A/S | Therapy with CD4 binding peptides and radiation |
| CN105492430B (zh) * | 2013-03-15 | 2017-10-10 | 基因泰克公司 | 取代的苯并噁唑及其使用方法 |
| WO2015102929A1 (en) * | 2013-12-30 | 2015-07-09 | Novartis Ag | Tricyclic sulfonamide derivatives |
| JP6568926B2 (ja) * | 2014-03-20 | 2019-08-28 | カペラ セラピューティクス，インコーポレーテッド | 癌の治療のためのｅｒｂｂチロシンキナーゼ阻害剤としてのベンゾイミダゾール誘導体 |
| GB201510019D0 (en) | 2015-06-09 | 2015-07-22 | Cancer Therapeutics Crc Pty Ltd | Compounds |
| WO2017218960A1 (en) | 2016-06-17 | 2017-12-21 | Fronthera U.S. Pharmaceuticals Llc | Hemoglobin modifier compounds and uses thereof |
| GB201713962D0 (en) | 2017-08-31 | 2017-10-18 | Ctxt Pty Ltd | Compounds |
| MX2020007131A (es) | 2017-11-29 | 2021-01-08 | Epizyme Inc | Inhibidores de histona acetiltransferasa de la familia myst. |
| GB201810092D0 (en) | 2018-06-20 | 2018-08-08 | Ctxt Pty Ltd | Compounds |
| GB201810581D0 (en) | 2018-06-28 | 2018-08-15 | Ctxt Pty Ltd | Compounds |
| KR20210057767A (ko) * | 2018-09-07 | 2021-05-21 | 치아타이 티안큉 파마수티컬 그룹 주식회사 | Crbn단백질에 작용하는 삼환식 화합물 |
| EA202092908A1 (ru) | 2018-09-28 | 2021-05-14 | Праксис Пресижн Медсинз, Инк. | Модуляторы ионных каналов |
| CA3137472A1 (en) | 2019-04-25 | 2020-10-29 | Bayer Aktiengesellschaft | Acyl sulfonamides for treating cancer |
| DK4299135T3 (da) * | 2019-06-18 | 2025-09-08 | Pfizer | Benzisoxazol-sulfonamid-derivater |
| US12545669B2 (en) | 2019-06-19 | 2026-02-10 | Pfizer Inc. | Cycloalkyl and heterocycloalkyl benzisoxazole sulfonamide derivatives |
-
2022
- 2022-08-10 US US18/682,647 patent/US20250145637A1/en active Pending
- 2022-08-10 WO PCT/CN2022/111395 patent/WO2023016484A1/zh not_active Ceased
- 2022-08-10 JP JP2024507166A patent/JP2024529068A/ja active Pending
- 2022-08-10 AU AU2022325367A patent/AU2022325367A1/en active Pending
- 2022-08-10 TW TW111130097A patent/TW202321263A/zh unknown
- 2022-08-10 KR KR1020247007144A patent/KR20240046530A/ko active Pending
- 2022-08-10 EP EP22855464.8A patent/EP4385989A4/en active Pending
- 2022-08-10 MX MX2024001777A patent/MX2024001777A/es unknown
- 2022-08-10 CN CN202280046780.6A patent/CN117597341A/zh active Pending
- 2022-08-10 CA CA3228411A patent/CA3228411A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024529068A5 (https=) | ||
| JP2024522766A5 (https=) | ||
| RU2018119173A (ru) | Производное бензофурана, способ его получения и его применение в медицине | |
| JP2025160318A5 (https=) | ||
| JP2022533260A5 (https=) | ||
| RU2017136715A (ru) | Производное имидазоизоиндола, способ его получения и медицинское применение | |
| JP2011516427A5 (https=) | ||
| JP2015078199A5 (https=) | ||
| RU2014153627A (ru) | Имидазо[1, 2-]пиридазиновые производные как ингибиторы киназ | |
| RU2013109132A (ru) | Химические соединения | |
| RU2013128612A (ru) | Соли и кристаллические формы индуцирующего апоптоз агента | |
| RU2020102453A (ru) | Фармацевтические композиции | |
| RU2017139515A (ru) | Фармацевтически активные соединения в качестве ингибиторов рецепторной тирозинкиназы семейства там | |
| JP2024519188A5 (https=) | ||
| JP2025509995A5 (https=) | ||
| JP2023534528A5 (https=) | ||
| JP2023502458A5 (https=) | ||
| JP2022071077A5 (https=) | ||
| TWI895686B (zh) | 合成喹唑啉化合物之方法 | |
| JP2025503969A5 (https=) | ||
| JP2020534300A5 (https=) | ||
| JP2020523348A5 (https=) | ||
| RU2013143520A (ru) | Новые химические соединения (варианты) и их применение для лечения онкологических заболеваний | |
| RU2014121334A (ru) | Соединения 5-(пиридин-2-иламино)-пиразин-2-карбонитрила и их терапевтическое применение | |
| JP2020517654A5 (https=) |